Bausch & Lomb LACRISERT User Manual

Prep Rinse the soft and flexible applicator with hot water. Shake off the excess. Pick up LACRISERT
(hydroxypropyl cellulose ophthalmic insert) by lightly touching it with the grooved tip of the applicator.
3 Simple Steps for Placement
®
1
Pocket
Gently grasp the outer corner
of the lower eyelid between your
thumb and index finger and pull
out to create a “pocket”.
2
Place
Place LACRISERT® by gently
brushing it on the inside
of the “pocket”.
Application Tips
• Add a drop or two of artificial tears after placement to expedite softening
• Put contact lens in first, then place LACRISERT
• If using makeup, put makeup on first, then place LACRISERT
• LACRISERT® may be used at night or in the morning
®
®
1
Lacrisert is soluble, and begins to soften.
3
Pull up and over
Pull the lower lid up and over
the LACRISERT®, then release.
Allow LACRISERT® to settle
comfortably in the “pocket”.
As Lacrisert dissovles throughout the day, it provides continuous lubrication and protection.
1
Slow-release Artificial Tear
for Continuous Lubrication
Once a Day*2
1,3-5
Please see Important Safety Information on back.
Indications and Usage
Incorrect Placement
LACRISERT® shouldn’t touch the white part of the eye or be visible on the rim of the lower lid.
Correct Placement
LACRISERT pink part under the lower eyelid.
When placed correctly, it should be completely out of sight and feel comfortable. LACRISERT®
acts like a slow release artificial tear to help provide ongoing lubrication and protection.
®
should rest in the
LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Important Safety Information
LACRISERT® (hydroxypropyl cellulose ophthalmic insert)
is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.
Instructions for inserting and removing LACRISERT®
should be carefully followed.
If improperly placed, LACRISERT® may result in corneal
abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery.
The following adverse reactions have been reported,
but were in most instances mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.
References: 1. Lamberts DW, Langston DP, Chu W. A clinical study of slow-releasing artificial tears. Ophthalmology. 1978;85(8):794-800. 2. LACRISERT package insert [Aton Pharma, Madison NJ].
3. Katz IM, Blackman WM. A soluble-sustained release ophthalmic delivery unit. Am J Ophthalmol.
1977;5(8):728-734. 4. Breslin CW, Katz J, Kaufman HE, Katz I. Slow release artificial tears. In:Leopold IH, Burns RF, eds. Symposium on ocular therapy. New York: Wiley, 1977;10:77-83. 5. Hovding G,
Aasved H. Slow-release artificial tears (SRAT) in dry eye disease. Acta Ophthalmol (Kbh). 1981;59:842-6.
Please see Prescribing Information that accompanies your prescription.
* In most patients, one LACRISERT® placed into each eye, once daily, is effective in providing
all-day symptom relief. Some patients may require twice-daily use for optimal results.
Lacrisert is a trademark of Valeant Pharmaceuticals International or its affiliates. Bausch + Lomb is a trademark of Bausch & Lomb Incorporated or its affiliates. ©2014 Bausch & Lomb Incorporated.
You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Please see accompanying full Prescribing Information, including Instructions for Use.
For more information on LACRISERT®, plus FREE samples and coupons, go to www.LACRISERT.com
Slow-release Artificial Tear
for Continuous Lubrication
Once a Day*2
US/LAC/14/0004
1,3-5
Loading...
+ 1 hidden pages